Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
This grant funds clinical studies of orphan products aimed at addressing unmet needs in rare diseases.
About this program
The Clinical Studies of Orphan Products grant supports research focused on the development of orphan products that target rare diseases. This funding opportunity is designed for researchers and institutions that are conducting clinical trials to evaluate the safety and efficacy of these products. The goal is to encourage innovative approaches to treating conditions that currently have limited or no treatment options available. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research. The grant aims to facilitate the advancement of medical knowledge and improve patient outcomes for individuals suffering from rare diseases. By providing financial support for clinical trials, this grant seeks to foster collaboration among researchers, healthcare providers, and industry stakeholders to bring new therapies to market.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research.